Use of freeze-dried mare's milk to reduce uric acid levels in blood serum

KZ13080UUndetermined Publication Date: 2026-10-02SAFONOV NIKOLAY ANDREEVICH
0 Cites 0 Cited by

Patent Information

Application Number
KZ20261409
Authority / Receiving Office
KZ · KZ
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2026-06-24
Publication Date
2026-10-02
Estimated Expiration
2034-06-24
Patent Text Reader

Abstract

This utility model relates to medicine, nutrition, and preventive and rehabilitative medicine, specifically to the use of a freeze-dried mare's milk product to reduce serum uric acid levels in adults. The essence of the utility model is that the freeze-dried product, made from fresh mare's milk, is administered orally at a dose of 30 g of dry substance dissolved in 200 ml of boiled water, twice daily, 30 minutes before meals, for 28 days. The study resulted in a reduction in serum uric acid levels after four weeks of freeze-dried mare's milk administration. In the adult study group, the mean uric acid concentration decreased from 293.05 ± 93.90 μmol / L to 241.42 ± 80.71 μmol / L, with a mean paired change of -51.63 μmol / L (p ≈ 9.3 × 10⁻⁷). This useful model can be used in outpatient practice, preventative programs, spa treatment, and rehabilitation medicine as a component of nutritional support for adults aimed at correcting uric acid levels. The product requires no special equipment and includes standard laboratory testing of uric acid levels before and after treatment.
Need to check novelty before this filing date? Find Prior Art